ZTTA 1
Latest Information Update: 25 Aug 1998
At a glance
- Originator Nonindustrial source
- Class Nootropics
- Mechanism of Action Prolyl endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 25 Aug 1998 No-Development-Reported for Cognition disorders in Japan (Unknown route)
- 05 Dec 1996 New profile
- 05 Dec 1996 Preclinical development for Cognition disorders in Japan (Unknown route)